OpportunityTitle: Limited Competition: Revision for Resuscitation Outcomes Center Randomized Clinical Trial (U01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following: Only the currently funded NHLBI Resuscitation Outcomes Centers are eligible to apply.
Description: The National Heart, Lung, and Blood Institute (NHLBI) invites research grant applications for a Revision award (formerly referred to as a competing supplement) for the Resuscitation Outcomes Consortium (RFA-HL-10-006) to conduct a multi-center, randomized, phase III trial that will test acute survival benefits of increased plasma: platelets: RBCs ratio (1:1:1) compared to 1:1:higher ratio (1:1:2 or 1:1:3), among patients predicted to receive massive blood transfusions.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;